Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| KROS (Keros Therapeutics, Inc.) | -47.10% | -27.33% | -39.85% | -25.55% | NA | NA | NA | … | … |
Data as of 06/04/2026, Common starting date is 04/09/2020
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| KROS (Keros Therapeutics, Inc.) | 04/09/2020 | 06/04/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -5.44 | -27.33 | -39.85 | -25.55 | NA | NA | NA | … | … | -47.10 | 32.85 | -60.19 | -17.20 | -17.93 | -17.05 | 227.03 |
| Sharpe Ratio | NA | -0.47 | -0.45 | -0.35 | NA | NA | NA | … | … | -1.46 | 0.60 | -0.46 | -0.39 | -0.28 | -0.24 | 5.33 |
| Standard Deviation(%) | NA | 47.52 | 93.04 | 83.41 | NA | NA | NA | … | … | 54.21 | 50.70 | 142.37 | 56.11 | 68.83 | 72.01 | 76.28 |
| Draw Down(%) | NA | 54.62 | 86.45 | 86.45 | NA | NA | NA | … | … | 51.33 | 40.68 | 76.70 | 54.28 | 61.17 | 61.12 | 42.13 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/04/2026, Common starting date is 04/09/2020
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| KROS (Keros Therapeutics, Inc.) |
-42.78%
Mar 2022 – Mar 2025 |
-29.08%
Mar 2021 – Mar 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| KROS (Keros Therapeutics, Inc.) |
18.53%
May 2020 – May 2023 |
-13.21%
May 2020 – May 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart